Natural Investments LLC Makes New Investment in Globe Life Inc. (NYSE:GL)

Natural Investments LLC purchased a new position in Globe Life Inc. (NYSE:GL) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,200 shares of the company’s stock, valued at approximately $356,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Versant Capital Management Inc raised its stake in Globe Life by 388.0% in the fourth quarter. Versant Capital Management Inc now owns 244 shares of the company’s stock valued at $27,000 after purchasing an additional 194 shares in the last quarter. Albion Financial Group UT purchased a new position in shares of Globe Life during the fourth quarter worth approximately $28,000. True Wealth Design LLC bought a new stake in shares of Globe Life in the 3rd quarter worth approximately $59,000. Cullen Frost Bankers Inc. lifted its holdings in shares of Globe Life by 3,157.9% in the 4th quarter. Cullen Frost Bankers Inc. now owns 619 shares of the company’s stock worth $69,000 after acquiring an additional 600 shares during the last quarter. Finally, Private Trust Co. NA lifted its holdings in shares of Globe Life by 67.5% in the 3rd quarter. Private Trust Co. NA now owns 670 shares of the company’s stock worth $71,000 after acquiring an additional 270 shares during the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.

Globe Life Stock Up 1.8 %

Shares of Globe Life stock opened at $124.79 on Wednesday. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50. The company’s fifty day simple moving average is $120.36 and its two-hundred day simple moving average is $111.81. The company has a market cap of $10.46 billion, a P/E ratio of 10.44 and a beta of 0.77. Globe Life Inc. has a 12-month low of $38.95 and a 12-month high of $131.39.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, topping analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. Research analysts anticipate that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Thursday, April 3rd will be given a $0.27 dividend. The ex-dividend date of this dividend is Thursday, April 3rd. This is an increase from Globe Life’s previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.87%. Globe Life’s dividend payout ratio is currently 9.04%.

Wall Street Analyst Weigh In

GL has been the subject of a number of recent research reports. BMO Capital Markets initiated coverage on shares of Globe Life in a report on Thursday, January 23rd. They issued a “market perform” rating and a $114.00 price objective for the company. Jefferies Financial Group boosted their price objective on shares of Globe Life from $107.00 to $114.00 and gave the stock a “hold” rating in a report on Tuesday, December 10th. Wells Fargo & Company boosted their price objective on shares of Globe Life from $126.00 to $141.00 and gave the stock an “overweight” rating in a report on Wednesday, February 19th. Morgan Stanley upped their price target on shares of Globe Life from $125.00 to $126.00 and gave the company an “equal weight” rating in a report on Friday, February 28th. Finally, Evercore ISI upgraded shares of Globe Life from an “in-line” rating to an “outperform” rating and upped their price target for the company from $132.00 to $143.00 in a report on Wednesday, January 8th. Five analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $135.60.

Insider Buying and Selling

In other Globe Life news, CEO Frank M. Svoboda sold 11,000 shares of the company’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $122.31, for a total transaction of $1,345,410.00. Following the transaction, the chief executive officer now owns 18,948 shares in the company, valued at approximately $2,317,529.88. This represents a 36.73 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CMO Jennifer Allison Haworth sold 9,000 shares of the company’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $112.91, for a total transaction of $1,016,190.00. Following the transaction, the chief marketing officer now owns 13,485 shares in the company, valued at $1,522,591.35. This represents a 40.03 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 61,338 shares of company stock worth $7,239,630 in the last quarter. Corporate insiders own 1.51% of the company’s stock.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.